GET THE APP

Mechanisms of Early Pregnancy-Mediated Breast Cancer Protection
..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Mechanisms of Early Pregnancy-Mediated Breast Cancer Protection


World Congress on Breast Cancer

August 03-05, 2015 Birmingham, UK

Fabienne Meier-Abt

University Hospital of Basel, Switzerland

Scientific Tracks Abstracts: J Cancer Sci Ther

Abstract :

Pregnancy at early, but not late age, has a substantial and life-long protective effect againstbreast cancer. The expected overall increase in breast cancer incidence in the coming yearsdemands the development of strategies to mimic early-age pregnancymediated protection.Recently, converging results on molecular and cellular mechanisms underlying the protectiveeffect of early-age pregnancy were reported in rodent models and women. In particular, earlyparity induces differentiation and downregulates the Wnt/Notch signaling ratio and the in vitro and in vivo proliferation potential of basal stem/progenitor cells in mice. These early parityinducedchanges of gene expression and dynamics of mammary stem/progenitor cells werecaused primarily by a decrease in the proportion of hormone-sensitive and Wnt4-secretingluminal epithelial cells. Furthermore, they were of life-long duration and absent upon latepregnancy. Similar findings were made in humans confirming that decreased hormone- andWnt4-mediated Wnt signaling in mammary stem/progenitor cells plays a key role in theprotective effect of early-age pregnancy against breast cancer. However, in addition to decreased Wnt signaling, increased cellular quiescence induced by TGF├?┬▓ signaling might also be involved in the breast cancer-protective effect of early pregnancy in humans. These congruent andcomplementary findings in mouse and human mammary epithelial stem/progenitor cells provide promising initial targets for translational studies directed toward the development ofpharmacological breast cancer prevention strategies.

Biography :

Fabienne Meier-Abt completed her MD at Yale University School of Medicine, New Haven, USA, and her PhD in experimental oncology at the Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. She is now working clinically in the Department of Internal Medicine at the University Hospital of Basel, Switzerland. Her scientific interests continue to be focused on translational cancer and stem cell research.

Google Scholar citation report
Citations: 3221

Cancer Science & Therapy received 3221 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward